Leukemia Clinical Trials in Nashville

Showing 681-700 of 1,521 trials

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

NCT05769959

The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, immune response and preliminary anti-tumor activity of RO7515629 alone in participants with advanced or metastatic solid tumors expressing human leukocyte antigen G (HLA-G).

Renal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more

Hoffmann-La Roche3 participantsStarted Jun 2023

Denver, Colorado, United States • Nashville, Tennessee, United States

TERMINATEDPhase 2< 1 mile

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

NCT02742090

The main objective of this study is to determine the progression free survival of umbralisib in participants who were intolerant to prior BTK (Bruton Tyrosine Kinase) inhibitors (ibrutinib, ACP-196, other) or prior PI3K-delta inhibitors (idelalisib, duvelisib, other).

Chronic Lymphocytic Leukemia

TG Therapeutics, Inc.51 participantsStarted Apr 2016

Huntsville, Alabama, United States • Washington D.C., District of Columbia, United States • Fort Myers, Florida, United States +12 more locations

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Leukemia Trials in Other Cities

Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

House Dust Mite Allergy Trial In Children

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Efficacy of Ginseng for Patients on Regorafenib

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Other Conditions in Nashville